CClinicalTrials.gg
Status unknownNCT04723420Updated Apr 13, 2023

Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not

An interventional study of Steamroller technique and Direct technique in Rhegmatogenous Retinal Detachment, sponsored by Sunnybrook Health Sciences Centre. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-13.

Sponsored by Sunnybrook Health Sciences Centre · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Aug 2020, registered Dec 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a randomized controlled trial comparing displacement of macula and the rapidity of reattachment of macula between two different positioning techniques after pneumatic retinopexy : Direct technique (patient is positioned so that the bubble is immediately placed directly over the retina break) and Steamroller technique (patient is initially positioned face down for 4-6 hours and subsequently changes their head position so that the bubble is then placed directly over the retina break).

Read the detailed description

Pneumatic retinopexy (PR) is an established treatment for rhegmatogenous retinal detachment (RRD). In our centre, PR is the most commonly performed procedure for primary RRD repair with a high retinal reattachment success rate. In this procedure, patients are required to position according to the site of pathology following injection of an intravitreal gas bubble. Some practitioners position the patient so that the gas bubble is immediately apposed directly against the retinal break (direct technique). Others favour the steamroller technique whereby the patient is initially positioned face down, then after 4-6 hours, the position is changed sequentially so that the bubble is rolled over the retina towards the break responsible for the detachment (steamroller technique). Variable visual acuity (VA) outcomes and metamorphopsia are common post-procedure complaints despite successful RRD repair with PR. It has been suggested that variability in functional outcomes may be associated with the timing and ease of reattachment of macula. The purpose of this prospective study is to evaluate whether the steamroller technique is superior to the direct technique in faster reattachment of macula with less macula displacement.

02

Conditions studied

  • Rhegmatogenous Retinal Detachment

Keywords

  • Pneumatic Retinopexy
  • Steamroll
  • Direct to break
03

In context

Retinal Detachment

207 studies on the registry are indexed under Retinal Detachment; 27 are open to participants now.

This study's planned enrollment of 60 is above the median of 50 across 136 interventional studies indexed under Retinal Detachment.

Browse Retinal Detachment studies →

Lead sponsor

Sunnybrook Health Sciences Centre is the lead sponsor of 566 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Primary RRD
  • Causative breaks over superior 8 clock hours
  • Single break or group of breaks
  • No or min proliferative vitreoretinopathy (PVR) (Grade A or B)
  • Other breaks or lattice in attached retina are allowed

Exclusion criteria

Exclusion Criteria:

  • Retinal break in the inferior 4 clock hours in detached retina
  • PVR Grade C or worse
  • Significant media opacity (Vitreous hemorrhage, dense cataract, cornea scar, etc)
  • Pre-existing ocular pathology [macula hole (MH), epiretinal membrane (ERM), cystoid macula edema (CME), age-related macula degeneration, myopic degeneration, advanced glaucoma, uveitis, amblyopia etc] or previous eye trauma with poor baseline vision
  • Previous pars plana vitrectomy
  • Age ≤18years old
  • Inadequate physical or mental competence to maintain the required postoperative head position
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Steamroller Technique

    Following intravitreal gas injection, patient positioned face down for 4-6 hours and subsequently patient changes the position of the head so that the bubble is then placed directly over the retina break.

    Other: Steamroller technique

  • Active comparator
    Direct Technique

    Following intravitreal gas injection, patient is immediately positioned so that the bubble is placed directly over the retina break.

    Other: Direct technique

Interventions

  • OtherSteamroller technique

    Following intravitreal gas injection, patient positioned face down for 4-6 hours and subsequently patient changes the position of the head so that the bubble is then placed directly over the retina break.

  • OtherDirect technique

    Following intravitreal gas injection, patient is immediately positioned so that the bubble is placed directly over the retina break.

06

What researchers measure

Primary outcomes

  1. Macular status at Day 1

    Assessment of macular status by optical coherence tomography at 24 hours after intervention to see which technique is most effective for reattaching the macula

    Time frame: 24hours post intervention

Secondary outcomes

  1. Anatomical displacement of macula and its changes with time.

    Measurement of retinal vessel imprinting on fundus autofluorescence

    Time frame: 1,2, 3 and 6 months post intervention

  2. Functional displacement of macula and its changes with time.

    Measurement of metamorphopsia with M-charts

    Time frame: 1,2, 3 and 6 months post intervention

  3. Macular Status

    Looking at macula status via optical coherence tomography after intervention to see which technique is more effective in reattaching the macula early

    Time frame: 1hour, 2hours, Day 2, Week 1, Week 2

  4. Visual acuity

    ETDRS

    Time frame: 1, 3 and 6 months post intervention

  5. Primary anatomical success

    Complete reattachment of retina via clinical fundus examination and optos fundus photography

    Time frame: 1, 3 and 6 months post intervention

07

Study locations

1 of 1 sites recruiting
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario M4N 3M5, Canada
    • Kenneth Eng, MD FRCSC · Contact · kenneth.eng@sunnybrook.ca · 416-480-4688
    • Kenneth Eng, MD FRCSC · Principal investigator
    • Peter Kertes, MD FRCSC · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04723420
Lead sponsor
Sunnybrook Health Sciences Centre
Responsible party
Dr. Kenneth Eng (Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not, Sunnybrook Health Sciences Centre) — Principal investigator
First posted
Jan 25, 2021
Start date
Aug 7, 2020
Primary completion
Dec 7, 2023 (estimated)
Completion
Dec 7, 2023 (estimated)
Last update
Apr 13, 2023

Study contacts

Study Coordinator
Contact
Cindy.Rutz@sunnybrook.ca
416-480-5091
Kenneth Eng, MD FRCSC
principal investigator · Sunnybrook Health Sciences Centre

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion